2,090
Views
33
CrossRef citations to date
0
Altmetric
Research Paper

MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55

, , , &
Pages 306-315 | Received 10 Oct 2017, Accepted 10 Dec 2017, Published online: 26 Mar 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Suqing Sun, Peng Wang, Lijie Ren, Hongli Wang, Yanli Zhan & Shimin Shan. (2021) Sevoflurane Suppresses Colon Cancer Cell Malignancy by Regulating circ-PI4KA. OncoTargets and Therapy 14, pages 3319-3333.
Read now
Yuhuan Li, Nina Wang, Jie Pan, Xinrui Wang, Yanling Zhao & Zongjun Guo. (2021) Hippocampal miRNA-144 Modulates Depressive-Like Behaviors in Rats by Targeting PTP1B. Neuropsychiatric Disease and Treatment 17, pages 389-399.
Read now
Jianhua Luo, Junsu Pan, Yan Jin, Mengyuan Li & Miao Chen. (2019) MiR-195-5p Inhibits Proliferation and Induces Apoptosis of Non-Small Cell Lung Cancer Cells by Targeting CEP55. OncoTargets and Therapy 12, pages 11465-11474.
Read now
Hua Li, Xichun Cui, Qiuyue Hu, Xiaolong Chen & Pengli Zhou. (2019) CLK3 Is A Direct Target Of miR-144 And Contributes To Aggressive Progression In Hepatocellular Carcinoma. OncoTargets and Therapy 12, pages 9201-9213.
Read now

Articles from other publishers (28)

James S. Brownjr.jr.. (2023) Comparison of Oncogenes, Tumor Suppressors, and MicroRNAs Between Schizophrenia and Glioma: The Balance of Power. Neuroscience & Biobehavioral Reviews 151, pages 105206.
Crossref
Youyi Xiong, Lin Li, Nan Wang, Fang Wang, Zhuo Chen, Luhong Han, Shan Jiang & Yuanting Gu. (2023) Circ_0001387 regulates SKA2 to accelerate breast cancer progression through miR ‐136‐5p . Thoracic Cancer 14:18, pages 1707-1718.
Crossref
Guo-Sheng Li, Wei Zhang, Wan-Ying Huang, Rong-Quan He, Zhi-Guang Huang, Xiang-Yu Gan, Zhen Yang, Yi-Wu Dang, Jin-Liang Kong, Hua-Fu Zhou & Gang Chen. (2023) CEP55: an immune-related predictive and prognostic molecular biomarker for multiple cancers. BMC Pulmonary Medicine 23:1.
Crossref
Qing Ye, Rebecca Raese, Dajie Luo, Shu Cao, Ying-Wooi Wan, Yong Qian & Nancy Lan Guo. (2023) MicroRNA, mRNA, and Proteomics Biomarkers and Therapeutic Targets for Improving Lung Cancer Treatment Outcomes. Cancers 15:8, pages 2294.
Crossref
Fang Jia, Lixia Zhang, Zhengye Jiang, Guowei Tan & Zhanxiang Wang. (2023) FZD1/KLF10-hsa-miR-4762-5p/miR-224-3p-circular RNAs axis as prognostic biomarkers and therapeutic targets for glioblastoma: a comprehensive report. BMC Medical Genomics 16:1.
Crossref
Sawsan Elgohary & Hend M. El Tayebi. (2023) Inflammasomes in breast cancer: the ignition spark of progression and resistance?. Expert Reviews in Molecular Medicine 25.
Crossref
Xiang Gao, Nanwei Xu, Kaisong Miao, Gao Huang & Yong Huang. (2022) Circ_0136666 aggravates osteosarcoma development through mediating miR-1244/CEP55 axis. Journal of Orthopaedic Surgery and Research 17:1.
Crossref
Yan Ju, Bin Yuan, Wenan Wu, Jin Zhao & Xiaorui Shi. (2021) CircRNA ANXA2 Promotes Lung Cancer Proliferation and Metastasis by Upregulating PDPK1 Expression. Journal of Oncology 2021, pages 1-15.
Crossref
Kevin Nathanael Ramanto, Kresnodityo Jatiputro Widianto, Stefanus Satrio Hadi Wibowo & David Agustriawan. (2021) The regulation of microRNA in each of cancer stage from two different ethnicities as potential biomarker for breast cancer. Computational Biology and Chemistry 93, pages 107497.
Crossref
Bhoomika Sharma, Vinay Randhawa, Kim Vaiphei, Vikas Gupta, Divya Dahiya & Navneet Agnihotri. (2021) Expression of miR-18a-5p, miR-144-3p, and miR-663b in colorectal cancer and their association with cholesterol homeostasis. The Journal of Steroid Biochemistry and Molecular Biology 208, pages 105822.
Crossref
Siyao Shen, Junhui Xiong, Zhigang Zeng, Hong Zhao, Xiaochun Zeng & Bin Fu. (2021) Toosendanin Affects the Occurrence and Development of Prostate Carcinoma Cells DU145 by Regulating Forkhead Box C2-Antisense RNA 1. Journal of Biomaterials and Tissue Engineering 11:3, pages 533-540.
Crossref
Rui Hua, Qing-jun Chu, Yao Zhou, Xuan Zhou, Da-xiong Huang & Yong-tong Zhu. (2020) MicroRNA-449a Suppresses Mouse Spermatogonia Proliferation via Inhibition of CEP55. Reproductive Sciences 28:2, pages 595-602.
Crossref
Jason R. Pettus, Darcy A. Kerr, Radu V. Stan, Julie Y. Tse, Einar F. Sverrisson, Julia A. Bridge & Konstantinos Linos. (2020) Primary myxoid and epithelioid mesenchymal tumor of the kidney with a novel GLI1‐FOXO4 fusion . Genes, Chromosomes and Cancer 60:2, pages 116-122.
Crossref
Li-Zhu Liao, Chih-Ta Chen, Nien-Chen Li, Liang-Chun Lin, Bo-Shih Huang, Ya-Hui Chang & Lu-Ping Chow. (2020) Y-Box Binding Protein-1 Promotes Epithelial-Mesenchymal Transition in Sorafenib-Resistant Hepatocellular Carcinoma Cells. International Journal of Molecular Sciences 22:1, pages 224.
Crossref
Jiafu Feng, Yongcan Guo, Yuanmeng Li, Jiawei Zeng, Yaodong Wang, Yuwei Yang, Gang Xie & Qian Feng. (2020) Tumor promoting effects of circRNA_001287 on renal cell carcinoma through miR-144-targeted CEP55. Journal of Experimental & Clinical Cancer Research 39:1.
Crossref
Bing Zhou, Xia Zhang, Ting Li, Rongping Xie, Jianbin Zhou, Yu Luo & Chunfen Yang. (2020) CircZDHHC20 represses the proliferation, migration and invasion in trophoblast cells by miR-144/GRHL2 axis. Cancer Cell International 20:1.
Crossref
Qiang Zhang, Xiaoyan Jin, Wenbiao Shi, Xin Chen, Wenyang Pang, Xiaodong Yu & Linjun Yang. (2020) A long non-coding RNA LINC00461-dependent mechanism underlying breast cancer invasion and migration via the miR-144-3p/KPNA2 axis. Cancer Cell International 20:1.
Crossref
Xiangkun Wu, Zhijian Zhao, Aisha Khan, Chao Cai, Daojun Lv, Di Gu & Yongda Liu. (2020) Identification of a Novel Signature and Construction of a Nomogram Predicting Overall Survival in Clear Cell Renal Cell Carcinoma. Frontiers in Genetics 11.
Crossref
Jun Sheng Wong & Yoke Kqueen Cheah. (2020) Potential miRNAs for miRNA-Based Therapeutics in Breast Cancer. Non-Coding RNA 6:3, pages 29.
Crossref
Xu Li, Wenjing Zou, Yuzhen Wang, Zijun Liao, Lina Li, Yang Zhai, Lingxiao Zhang, Shanzhi Gu & Xinhan Zhao. (2020) Plasma‐based microRNA signatures in early diagnosis of breast cancer. Molecular Genetics & Genomic Medicine 8:5.
Crossref
Omid Kooshkaki, Zohre Rezaei, Meysam Rahmati, Parviz Vahedi, Afshin Derakhshani, Oronzo Brunetti, Amir Baghbanzadeh, Behzad Mansoori, Nicola Silvestris & Behzad Baradaran. (2020) MiR-144: A New Possible Therapeutic Target and Diagnostic/Prognostic Tool in Cancers. International Journal of Molecular Sciences 21:7, pages 2578.
Crossref
Qian Zheng, Qin Zhu, Cuiping Li, Shuang Hao, Jianguo Li, Xin Yu, Dengmei Qi & Yu Pan. (2020) microRNA-144 functions as a diagnostic and prognostic marker for retinoblastoma. Clinics 75, pages e1804.
Crossref
Wei Wang, Yan Dong, Xiaoyan Li, Yingying Pan, Jiexin Du & Daotong Liu. (2019) MicroRNA‑431 serves as a tumor inhibitor in breast cancer through targeting FGF9. Oncology Letters.
Crossref
Mohammad Mijanur Rahman, Andrew C. Brane & Trygve O. Tollefsbol. (2019) MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer. Cells 8:10, pages 1214.
Crossref
Cuimin Chen, Chunyan Zhao, Cao Gu, Xiao Cui & Jinhui Wu. (2019) MiRNA-144-3p inhibits high glucose induced cell proliferation through suppressing FGF16. Bioscience Reports 39:7.
Crossref
Yingping Zhu, Yanping Wu, Liwei Yang, Xiaoqing Dou, Jun Jiang & Liangping Wang. (2019) Long non‐coding RNA activated by transforming growth factor‐β promotes proliferation and invasion of cervical cancer cells by regulating the miR‐144/ITGA6 axis. Experimental Physiology 104:6, pages 837-844.
Crossref
Min Sun, Di Wu, Ke Zhou, Heng Li, Xingrui Gong, Qiong Wei, Mengyu Du, Peijie Lei, Jin Zha, Hongrui Zhu, Xinsheng Gu & Dong Huang. (2019) An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network. Breast Cancer Research and Treatment 175:1, pages 59-75.
Crossref
Hongyan Lu, Haoran Liu, Xiaoqi Yang, Tao Ye, Peng Lv, Xiaoliang Wu & Zhangqun Ye. (2019) LncRNA BLACAT1 May Serve as a Prognostic Predictor in Cancer: Evidence from a Meta-Analysis. BioMed Research International 2019, pages 1-10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.